Cargando…
Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
BACKGROUND: In people with human immunodeficiency virus [HIV] presenting with advanced disease, rates of virologic success may be lower than expected. The Reflate TB2 trial did not show non-inferiority of raltegravir versus efavirenz in people with HIV (PWH) treated for tuberculosis. We aimed to ide...
Autores principales: | De Castro, Nathalie, Chazallon, Corine, N'takpe, Jean-Baptiste, Timana, Isabel, Escada, Rodrigo, Wagner, Sandra, Messou, Eugène, Eholie, Serge, Bhatt, Nilesh, Khosa, Celso, Laureillard, Didier, Do Chau, Giang, Veloso, Valdilea G, Delaugerre, Constance, Anglaret, Xavier, Molina, Jean-Michel, Grinsztejn, Beatriz, Marcy, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757687/ https://www.ncbi.nlm.nih.gov/pubmed/36540390 http://dx.doi.org/10.1093/ofid/ofac628 |
Ejemplares similares
-
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
por: Eholié, Serge P., et al.
Publicado: (2016) -
High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d’Ivoire
por: Ghehi, Calixte, et al.
Publicado: (2017) -
Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'Ivoire
por: Jean, Kévin, et al.
Publicado: (2014) -
Dissection aortique anévrismale chez un adulte infecté par le VIH-1 dans le cadre d'un syndrome de reconstitution immune avec tuberculose
por: Moh, Desmorys Raoul, et al.
Publicado: (2018) -
Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy
por: Delagreverie, Héloïse M, et al.
Publicado: (2020)